Rome, Italy

Monica Rinaldi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monica Rinaldi. Retrieved from https://idiyas.com/inventor/monica-rinaldi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Monica Rinaldi: Pioneering Innovations in Cancer Immunotherapy

Introduction

Monica Rinaldi is an innovative inventor based in Rome, Italy, known for her significant contributions to cancer research. With a focus on immunogenic peptides, her work aims to enhance the immune response against various types of cancers, particularly colorectal carcinoma.

Latest Patents

Rinaldi holds a patent for her invention titled "Anti tumoral immunogenic peptides and vaccine thereof." This groundbreaking invention relates to novel, Frizzled-like, immunogenic peptides that can stimulate the immune system, offering promising avenues for cancer treatment.

Career Highlights

Throughout her career, Monica Rinaldi has made substantial strides in her field. Her dedication to cancer immunotherapy has positioned her as a key figure in innovative research efforts that address significant health challenges.

Collaborations

Monica frequently collaborates with notable colleagues, including Vito M. Fazio and Enrico Garaci. These collaborations have enriched her research endeavors and expanded the impact of her innovations in the medical community.

Conclusion

Monica Rinaldi's contributions to the field of cancer immunotherapy exemplify the critical role that innovators play in advancing medical science. With her patented innovations, she continues to pave the way for new therapeutic strategies, contributing to the ongoing battle against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…